Abdullah Al Mahmud

Abdullah Al Mahmud

Auto-generated profile, based on publicly available information

Abdullah Al Mahmud

Nutrition and Clinical Services Division, International Center for Diarrhoeal Disease Research, Bangladesh

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2013 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
GCGrace J. Chan
Grace J. Chan
ABAbdullah H. Baqui
Abdullah H. Baqui
JMJoyanta K. Modak
Joyanta K. Modak
AMAdriana Murillo‐Chaves
Adriana Murillo‐Chaves
AMAbdullah A. Mahmud
Abdullah A. Mahmud
SSSamir K. Saha
Samir K. Saha
Objective: To estimate the risk of early‐onset neonatal sepsis among newborns of mothers with chorioamnionitis and/or bacterial colonisation in Dhaka.Methods: We conducted a cohort study at a maternity centre following 600 mother–newborn pairs. Women with a positive bacterial vaginal culture or positive Group B streptococcus (GBS) rectal culture during labour were classified as colonised. Women with placental histopathology demonstrating signs of maternal or foetal inflammation were classified as having chorioamnionitis. Newborns were followed over the first 7 days of life. The primary outcome measure was physician or community health worker diagnosis of neonatal sepsis following modified World Health Organization Integrated Management of Childhood Illnesses criteria. Survival analysis was conducted with non‐parametric, parametric and semiparametric models.Results: Of the 600 mother–newborn pairs, 12.8% of newborns were diagnosed with early‐onset sepsis. Five hundred and forty‐three women had both colonisation and chorioamnionitis data, 55.4% of mothers were non‐exposed, 31.7% were only colonised and 12.9% had chorioamnionitis regardless of colonisation status.After adjusting for birthweight, sex, maternal characteristics and wealth, newborns of only colonised mothers developed sepsis 63% faster and had a 71% higher risk of developing sepsis than their non‐exposed counterparts (RT = 0.37, 95% CI 0.14–1.03; RH = 1.71, 95% CI 1.00–2.94). Newborns of mothers with chorioamnionitis developed sepsis 74% faster and had a 111% higher risk of developing sepsis (RT = 0.26, 95% CI 0.07–0.94; RH = 2.11, 95% CI 1.06–4.21).Conclusions: Newborns born to mothers with colonisation or chorioamnionitis developed sepsis faster and were at higher risk of developing sepsis in Dhaka.

7 June 2021 in Current Developments in Nutrition
Verified
Journal Article
Open access
PDF file
KOKaren O’cAllaghan
Karen O’cAllaghan
SSShaila Shaila
Shaila Shaila
FFFarzana Fariha
Farzana Fariha
JHJennifer Harrington
Jennifer Harrington
AMAbdullah Al Mahmud
Abdullah Al Mahmud
DRDaniel Roth
Daniel Roth
Maternal vitamin D status has gained substantial attention as a modifiable contributor to offspring musculoskeletal health, yet there is a paucity of trial-derived data to corroborate effects of prenatal or postpartum vitamin D supplementation on offspring bone mass accrual. Among maternal-infant pairs in Bangladesh, we aimed to examine the hypothesized causal association of early life vitamin D exposure with musculoskeletal health in childhood. In a double-blind dose-ranging trial of maternal vitamin D3 supplementation (Maternal Vitamin D for Infant Growth Trial), healthy pregnant women (n = 1300) were recruited at 17–24 weeks’ gestation and randomly assigned to receive a prenatal; postpartum regimen of 0;0,4200;0,16,800;0,28,000;0 or 28,000;28,000 IU vitamin D3/week until 26 weeks postpartum. In a follow-up study of offspring at 4 years of age (n = 642), bone mineral content (BMC) and bone mineral density (BMD) were measured by dual-energy X-ray absorptiometry. Between-group differences were assessed by independent t-tests (28,000 IU/week prenatally vs placebo) and linear regression (each vitamin D treatment group vs placebo) with bootstrapping (1000 replications). Whole-body (WB), total-body-less-head (TBLH) and head-only BMC were similar in the combined high-dose prenatal and placebo groups (mean difference [95% CI] = 6.81g [−8.70, 22.32], 0.61g [−10.90, 12.13] and 1.71g [−3.54, 6.96], respectively). None of the mean values for WB or TBLH BMC or BMD in each vitamin D group were different from placebo (P > 0.05 for all comparisons). Although head BMD was slightly greater in offspring of women assigned to the 28,000;28,000 IU regimen compared to placebo (mean difference [95% CI] = 0.024g/cm2 [0.0009, 0.047], P = 0.042), the effect was attenuated and no longer significant upon adjustment for child height, weight, and sex (P = 0.11). In a population with high prevalence of vitamin D deficiency, our findings do not support the use of maternal prenatal vitamin D supplementation, with or without postpartum supplementation, for improvement of child BMC or BMD at 4 years of age. Canadian Institutes for Health Research and the Bill and Melinda Gates Foundation.